Facilitating enhanced 3D visualization of skeletal anatomy, the BoneEnhance machine learning module reportedly provides automated segmentation of bone and surrounding tissues for the Accuro XV ultrasound system.
|Articles|April 14, 2020
FDA Clears Machine Learning-Enabled Ultrasound for Spine Surgery
Author(s)Whitney J. Palmer
510(k) clearance given to product for use in real-time surgery.
Advertisement
Ultrasound can now be used real-time during spinal surgery. The Food & Drug Administration announced Tuesday it has awarded 510(k) clearance to TDi™ for its SonoVision™ ultrasound platform.
According to a company statement, SonoVision™ is the first machine learning-enabled ultrasound platform designed for intraoperative access to the spine.
“With this clearance, TDi™ ushers in a new era of innovations related to soft tissue imaging in spine surgery and the beginning of a much broader trend of artificial intelligence and machine learning being applied to satisfy challenging clinical requirements of spine surgery,” said Alex Kulianov, TDi™ chairman and chief executive officer.
SonoVision™ uses image-processing algorithms to differentiate between nerve, muscle, bone, and vessels during real-time. With FDA clearance, Kulianov said, it can be used as an imaging modality for spine surgery. Work is currently being done to develop expanded procedural applications, such as posterior access to the spine, 3D imaging, and image-guided navigation integration.
According to TDi™ officials, SonoVision™ will accelerate commercialization efforts in 2020.
Advertisement
Related to this article
A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
Catch up on the top radiology content of the past week.
For patients with hepatocellular carcinoma (HCC), perfusion beyond tumor margin on contrast-enhanced ultrasound that exceeds gray-scale ultrasound tumor measurement by 5 mm is associated with a 76 percent higher risk of worse recurrence-free survival, according to newly published research.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on the top radiology content of the past week.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Could Photon-Counting CT Have an Impact as a Platform for Molecular Imaging?
2
FDA Clears Machine Learning Module for Emerging Musculoskeletal Ultrasound Platform
3
What’s Next for AI in Radiology?: Facilitating Data Orchestration Over Fragmentation
4
Can the Kaiser Score with Breast MRI Improve Clarity for BI-RADS 0 and 4 Assessments on Mammography and Ultrasound?
5